Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 165

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Cardiovascular Molecular Imaging: Focus on Clinical Translation

Open access
Chen, Ian Y., Wu, Joseph C. · 2011 · Circulation

Abstract

The past few decades have seen an explosion in the knowledge of the molecular basis of cardiovascular diseases owing to rapid advances in molecular biology research. An improved understanding of disease pathogenesis at the genomic, transcriptional, and proteomic levels has led to the discovery of promising experimental strategies for the prevention, diagnosis, and treatment of cardiovascular disease. Unfortunately, only a minute number of these strategies have survived the rigors of preclinical and clinical trials to become therapeutically useful. Furthermore, even these successful strategies must endure a prolonged process of translation from bench to bedside, partially owing to the lack of tools to directly interrogate the molecular events in patients. The strong impetus to develop noninvasive imaging techniques to visualize molecular changes in patients has given birth to the field of molecular imaging.1,2 Molecular imaging has its roots in nuclear medicine, in which radiolabeled imaging probes are injected into living subjects to assess the functionality of different organ systems. Unlike conventional diagnostic imaging techniques (eg, radiography and computed tomography [CT]) that delineate the anatomy of the cardiovascular system (eg, coronary luminal diameter), molecular imaging techniques have been designed and validated to study much smaller-scale molecular events (eg, gene expression) that may underlie disease processes. The complexity of molecular imaging lies in the requirement for molecular targeting, the design of which requires a solid understanding of the pharmacokinetics of the imaging probe and how it interacts with the molecular target. When the target is proven to be a biomarker, molecular imaging becomes a valuable tool for detecting disease before its clinical manifestation, stratifying disease severity, predicting disease progression, monitoring treatment efficacy, and prognosticating disease. These challenges must be met before the true potential of personalized medicine can be fully realized.3 Significant advances have been made in molecular imaging …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.109.916338

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 165

Metadata

Authors
Chen, I. Y., & Wu, J. C.
Venue
Circulation
Published
2011-02
Volume
123
Issue
4
Pages
425-443
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2087447022
Cited by
165
References
15
FWCI
16.32
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.